Every breath you take: The value of the electronic nose (e-nose) technology in the early detection of lung cancer.

[1]  Giorgio Pennazza,et al.  Narrowing the gap between breathprinting and disease diagnosis, a sensor perspective , 2013 .

[2]  A. Dirksen,et al.  Lung Cancer Screening and Video-Assisted Thoracic Surgery , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  Giorgio Pennazza,et al.  Design and Test of a Biosensor-Based Multisensorial System: A Proof of Concept Study , 2013, Sensors.

[4]  N. Peled,et al.  Exhaled breath analysis for the early detection of lung cancer: recent developments and future prospects , 2017, Lung Cancer.

[5]  David R. Jones,et al.  Results of the national lung cancer screening trial: where are we now? , 2015, Thoracic surgery clinics.

[6]  F. Fiore,et al.  Management of non-small cell lung cancer in the era of personalized medicine. , 2016, The international journal of biochemistry & cell biology.

[7]  Hossam Haick,et al.  Assessment, origin, and implementation of breath volatile cancer markers. , 2014, Chemical Society reviews.

[8]  John K. Field,et al.  Perspective: The screening imperative , 2014, Nature.

[9]  Giorgio Pennazza,et al.  BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  A. Bharat,et al.  Impact of video-assisted thoracoscopic surgery on benign resections for solitary pulmonary nodules. , 2012, The Annals of thoracic surgery.

[11]  Giorgio Pennazza,et al.  The lung cancer breath signature: a comparative analysis of exhaled breath and air sampled from inside the lungs , 2015, Scientific Reports.

[12]  M. Bousamra,et al.  Normalization of Exhaled Carbonyl Compounds After Lung Cancer Resection , 2016, The Annals of thoracic surgery.

[13]  R. Rosell,et al.  Real-time liquid biopsies become a reality in cancer treatment. , 2015, Annals of translational medicine.

[14]  M. Grinstaff,et al.  Nanotechnology applications in thoracic surgery. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[16]  M. Santonico,et al.  Detection and identification of cancers by the electronic nose. , 2012, Expert opinion on medical diagnostics.

[17]  S. Senan,et al.  When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis. , 2014, Chest.

[18]  Ulrike Tisch,et al.  A nanomaterial-based breath test for short-term follow-up after lung tumor resection. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[19]  Ulrike Tisch,et al.  Classification of lung cancer histology by gold nanoparticle sensors. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[20]  Giorgio Pennazza,et al.  An investigation on electronic nose diagnosis of lung cancer. , 2010, Lung cancer.

[21]  Hossam Haick,et al.  Detection of Lung Cancer and EGFR Mutation by Electronic Nose System , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[22]  Giorgio Pennazza,et al.  Reproducibility and Respiratory Function Correlates of Exhaled Breath Fingerprint in Chronic Obstructive Pulmonary Disease , 2012, PloS one.

[23]  High sensitivity for lung cancer detection using analysis of exhaled carbonyl compounds. , 2015, The Journal of thoracic and cardiovascular surgery.

[24]  H. Groen,et al.  Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals , 2013, European Radiology.

[25]  R. Franco,et al.  EGFR mutations in lung cancer: from tissue testing to liquid biopsy. , 2015, Future oncology.

[26]  Radu Ionescu,et al.  Volatile fingerprints of cancer specific genetic mutations. , 2013, Nanomedicine : nanotechnology, biology, and medicine.